SBFM (Sunshine Biopharma) Revenue Growth QoQ

Corporate company logo of sunshinebiopharma.com (SBFM)

Sunshine Biopharma (SBFM) relies on a dedicated staff of oncologists while actively recruiting foreign compliance experts. Drug production is fully outsourced to contract manufacturing organizations (CMO). Financial stability remains low, as development depends on new investments. This chart of quarterly revenue growth reflects current dynamics, with the indicator holding around 0.30.

SBFM (Sunshine Biopharma Inc.) Quarterly Revenue Increase history from 07/04/2022 to 11/20/2026

Financial and market metric breakdowns for Sunshine Biopharma (SBFM)

- business market valuation indicators:
Basic company analysis:Sunshine Biopharma, Inc. - SBFM
Mass-produced product of Sunshine Biopharma Inc.

Quarterly revenue growth measures the rate of change in operating income over a three-month period, allowing for an assessment of the business's fundamental momentum and the risk of asset impairment should sales slow. By analyzing quarterly sales dynamics, an investor can track the commercial efficiency of Sunshine Biopharma (SBFM) within the anti-adhesive drug segment, evaluating the company's ability to scale deliveries to oncology centers to block tumor metastasis.

Competing companies

BeiGene Oncology - Quarterly Revenue Growth|HALO: Revenue Growth QoQ|Revolution Medicines Corp (RVMD) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Ascentage Pharma Group International (AAPG)|Revenue Growth QoQ CG Oncology, Inc.|Quarterly Revenue Growth Rate UroGen Pharma Corp URGN|Quarterly Revenue Growth BCAX|Personalis, Inc. - Sales Growth QoQ|Erasca - Quarterly Sales Growth|Quarterly Revenue Increase DCTH|YMAB: Quarterly Sales Growth|Quarterly Revenue Growth Rate Aura Corp|CADL: Quarterly Revenue Growth|ARAY - Quarterly Sales Growth Rate|SLS (SELLAS Life Sciences Group, Inc.) - Quarterly Revenue Growth|ACTU: Quarterly Revenue Increase|Revenue Growth QoQ citiusonc.com (CTOR)|Quarterly Sales Growth Rate TuHURA Biosciences|Revenue Growth QoQ Protara Therapeutics TARA|Fate Therapeutics (FATE) - Quarterly Revenue Growth Rate|WHWK - Revenue Growth QoQ|Quarterly Revenue Growth Rate TScan Therapeutics Inc|championsoncology.com (CSBR) - Revenue Growth QoQ|Sales Growth QoQ XBIT|Quarterly Sales Growth CVM|Sales Growth QoQ OSTX (OS Therapies Incorporated)|Quarterly Revenue Growth RADX|ARTV: Revenue Dynamics QoQ|Quarterly Revenue Growth ANL (Adlai Nortye Ltd)|VERU - Quarterly Sales Growth|tempesttx.com - Quarterly Revenue Growth|Quarterly Revenue Increase XLO (xiliotx.com)|RENB: Quarterly Revenue Growth|Quarterly Sales Growth Mural Oncology plc|Revenue Growth QoQ Kairos Pharma Inc|OKUR: Quarterly Revenue Increase|Quarterly Revenue Growth GDTC|CRIS (Curis) - Quarterly Revenue Increase|Revenue Growth QoQ apollomicsinc.com APLM|THAR: Sales Growth QoQ|advanbiomed.com - Quarterly Revenue Growth|Quarterly Revenue Increase GNPX (Genprex, Inc)|Calidi Biotherapeutics Inc. (CLDI) - Revenue Growth QoQ|Quarterly Sales Growth Xenetic Biosciences Inc.|Revenue Growth QoQ Salarius Pharmaceuticals Inc|PPBT: Quarterly Revenue Increase|Quarterly Revenue Growth AONC|BGNE (BeOne Medicines) - Quarterly Revenue Increase|Checkpoint Therapeutics, Inc - Quarterly Sales Growth|elevationoncology.com (ELEV) - Quarterly Revenue Growth Rate|iCAD Inc. - Quarterly Revenue Growth|Quarterly Revenue Growth Rate Ikena Oncology|NTBL: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Viracta (VIRX)|MOR (MorphoSys AG) - Quarterly Revenue Growth|NAYA: Quarterly Revenue Increase|Revenue Growth QoQ Ascentage Pharma Group Ltd (AAPGV)